...
首页> 外文期刊>Asian journal of surgery >Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer
【24h】

Persistent extramural vascular invasion positivity on magnetic resonance imaging after neoadjuvant chemoradiotherapy predicts poor outcome in rectal cancer

机译:Neoadjuvant ChemorAdiotaperapation治疗磁共振成像对直肠癌的差异

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BackgroundIn rectal cancer, extramural vascular invasion (EMVI) is the presence of tumour cells in blood vessels outside the muscular layer, which is associated with poor prognosis. Regression of EMVI on MRI following neoadjuvant chemoradiotherapy or its persistence may have prognostic implications.MethodsThis retrospective study included 52 patients with rectal cancer who underwent total mesorectal excision following long-course neoadjuvant chemoradiotherapy (CRT). EMVI assessments were done on previous pelvic MRIs obtained before neoadjuvant CRT and eight weeks after the completion of neoadjuvant chemoradiotherapy in initially EMVI positive cases.ResultsPersistently EMVI positive patients had worse overall survival and disease-free survival compared to initially EMVI negative patients and patients who returned to negative (p?
机译:背景型直肠癌,露营血管侵袭(EMVI)是肌血层外的肿瘤细胞存在,其预后差有关。 Neoadjuvant Chemoradiotherapy或其持久性后,EMVI对MRI的回归可能具有预后意义。方法包括52例直肠癌患者,在长期内辅助化学疗法(CRT)之后接受过介性切除的全部介性切除。 EMVI评估是在Neoadjuvant CRT之前获得的先前骨盆MRIS和Neoadjuvant ChemorAdiOurapation初始EMVI阳性病例的八周完成。与最初的EMVI阴性患者和返回的患者相比,EMVI阳性患者的总生存和无病生存率较差为负(两者都是p?<0.001)。多变量分析鉴定了Neoadjuvant治疗后持久的EMVI积极性(HR,102.9; p?= 0.003)作为大的整体存活率的重要独立预测因子;持续的EMVI阳性(HR,17.0; p?0.002),Neoadjuvant治疗后的Mesorectal筋膜参与(HR,8.0; p?= 0.017),分化差(HR,10.3,P?= 0.012)显着无病无病生存的独立预测因子。新辅助治疗后的巨大EMVI积极性似乎是整体生存差的独立因素;和持续的EMVI积极性以及介质筋膜参与后Neoadjuvant治疗MRI和差的分化似乎是直肠癌患者无病生存率的重要预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号